デコイ・セラピューティクス
Decoy Therapeutics Inc.
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -4.46 | $0 | -$3M |
| 2026 Q1 | -4.18 | $0 | -$3M |
| 2025 Q4 | -18.64 | $0 | -$1M |
| 2025 Q3 | -1.81 | $0 | -$2M |
| 2025 Q2 | -6.77 | $0 | -$862,297 |
| 2025 Q1 | -15.41 | $0 | -$1M |
| 2024 Q4 |
| -15.24 |
| $0 |
| -$742,518 |
| 2024 Q3 | -11.38 | $0 | -$1M |